| 1 |
Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy |
|
| | Yan-Ni Wang, Hao-Yu Feng, Xin Nie, Ya-Mei Zhang, Liang Zou, Xia Li, Xiao-Yong Yu, Ying-Yong Zhao | | | Frontiers in Pharmacology. 2022; 13 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/ß-catenin signalling pathway |
|
| | Yan-Ni Wang, Hong-Jiao Liu, Li-Li Ren, Ping Suo, Liang Zou, Ya-Mei Zhang, Xiao-Yong Yu, Ying-Yong Zhao | | | Frontiers in Pharmacology. 2022; 13 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Recent advances of gut microbiota in chronic kidney disease patients |
|
| | Ying-Yong Zhao | | | Exploration of Medicine. 2022; : 260 | | | [Pubmed] [Google Scholar] [DOI] | |
|
